We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
51
BioCryst Pharmaceuticals
BCRX
$2.36B
– –
-216,327
Closed -$2.73M
BCYC
52
Bicycle Therapeutics
BCYC
$278M
– –
-67,625
Closed -$1.57M
BDN
53
Brandywine Realty Trust
BDN
$554M
– –
-719,160
Closed -$4.85M
BEKE icon
54
KE Holdings
BEKE
$18.7B
– –
-182,986
Closed -$3.21M
BIIB icon
55
Biogen
BIIB
$30.5B
– –
-5,950
Closed -$1.59M
BNZI icon
56
Banzai International
BNZI
$6.33M
– –
-24
Closed -$2.35M
BSX icon
57
Boston Scientific
BSX
$71.4B
– –
-70,005
Closed -$2.71M
BTM
58
DELISTED
Bitcoin Depot
BTM
– –
-26,261
Closed -$1.82M
BTU icon
59
PUT
Peabody Energy
BTU
$2.87B
– –
-23,000
Closed -$38K
CC icon
60
Chemours
CC
$2.27B
– –
-112,121
Closed -$2.76M
CCI icon
61
Crown Castle
CCI
$32.7B
– –
-107,248
Closed -$15.5M
CCL icon
62
PUT
Carnival Corporation Ltd
CCL
$39.4B
– –
-1,006,000
Closed -$1.72M
CEG icon
63
Constellation Energy
CEG
$93.2B
– –
-118,087
Closed -$9.82M
CF icon
64
CF Industries
CF
$17.9B
– –
-77,637
Closed -$7.47M
CHH icon
65
Choice Hotels
CHH
$4.99B
– –
-188,257
Closed -$20.6M
CHR icon
66
Cheer Holding
CHR
$3.43M
– –
-710
Closed -$1.58M
CME icon
67
CME Group
CME
$95B
– –
-16,000
Closed -$2.83M
CMG icon
68
Chipotle Mexican Grill
CMG
$42.7B
– –
-258,550
Closed -$7.77M
CMI icon
69
Cummins
CMI
$88.7B
– –
-44,816
Closed -$9.12M
CNTB
70
Connect Biopharma Holdings
CNTB
$138M
– –
-613,931
Closed -$792K
COCH icon
71
Envoy Medical
COCH
$52.4M
– –
-427,660
Closed -$4.2M
COIN icon
72
Coinbase
COIN
$38.4B
– –
-23,000
Closed -$1.48M
COP icon
73
ConocoPhillips
COP
$142B
– –
-43,016
Closed -$4.4M
CP icon
74
Canadian Pacific Kansas City
CP
$79.3B
– –
-44,168
Closed -$2.95M
CPRI icon
75
PUT
Capri Holdings
CPRI
$1.72B
– –
-21,300
Closed -$247K
1 2
3
4 5

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.